Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma Interventions: Drug: Toripalimab; Radiation: IMRT to the nasopharynx and neck; Drug: Gemcitabine and Cisplatin Chemotherapy; Drug: Adjuvant chemotherapy with Capecitabine Sponsors: Fudan University; Fudan University Eye and ENT Hospital; Anhui Provincial Hospital; Sir Run Run Shaw Hospital; Hangzhou Cancer Hospital; Ningbo Medical Center Lihuili Hospital; The First People's Hospital of Changzhou; Cancer Hospital of Chinese Academ y of Medical Science, Shenzhen Center; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; Nanfang Hospital of Southern Medical University; Shenzhen People's Hospital; First Affiliated Hospital of Xi'anJiaotong Univerisity; Guangzhou Panyu Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Hospitals | Nasopharyngeal Cancer | Research | Science | Xeloda